Clinical Trial Update: 4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates that 4D-125 is being studied in Phase 1/2 for X-Linked Retinitis Pigmentosa and the study is currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Retinitis Pigmentosa

Drugs mentioned

• 4D-125

Snippet

Sponsor: 4D Molecular Therapeutics | Conditions: X-Linked Retinitis Pigmentosa | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING